Crossmark

HSP90 inhibitors as a future therapeutic strategy in diabetes-driven atherosclerosis

Crossref DOI link: https://doi.org/10.1016/j.artere.2017.02.001

Published Print: 2017-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Vázquez-Carrera, Manuel
License Information

Text and Data Mining valid from 2017-03-01
More Information

This article is maintained by: Elsevier

Article Title: HSP90 inhibitors as a future therapeutic strategy in diabetes-driven atherosclerosis

Journal Title: Clínica e Investigación en Arteriosclerosis (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.artere.2017.02.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.arteri.2017.02.001

Content Type: article

Copyright: © 2017 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Arteriosclerosis.